Amar Maletira
Analyst · William Blair. Your line is open
Thank you, Bill. Fiscal Q1 results exceeded the high end of guidance as revenue of v195.2 million topped our guidance range of $173 million to $193 million. NSE revenue was better-than-expected, primarily driven by strength in our field test instruments, partially offset by weakness in our lab and production. Compared to our expectations, we also saw some upside in OSP’s anti-counterfeiting revenue. Viavi revenue declined 7.4% year-on-year with a 9.2% decline from NSE and 2.5% decline in OSP. We are pleased with our expense management. Operating expenses at $93.1 million declined 9.4% from a year ago levels of $102.8 million. As a result, despite lower revenue levels, we achieved an overall operating margins of 15.1%, which is an expansion of 210 basis points from prior year’s operating margin of 13%. EPS at $0.11 grew $0.02 or 22.2% year-over-year and exceeded our guidance range of $.06 to $.09. Now, moving to our Q1 results by business segments, starting with NSE. NSE revenue at $140.8 million, exceeded the guidance range of $122 million to $138 million where NE revenue declined 5.7% while SE revenue fell 20.3% from a year ago. NSE gross margins at 64.7% improved 100 basis points from last year as SE gross margin of 70.7% improved 1,220 basis points, partially offset by a decline of 220 basis points in NE gross margins at 63.1%. The improvement in SE’s gross margin was a result of a higher acceptances of our assurance solutions this quarter and a favorable revenue mix as we have discontinued unprofitable product lines through the SE restructuring announced in January 2017. NSE operating expense in the quarter was $83.9 million, a reduction of 11.3% from year-ago at $94.6 million. This OPEX reduction is a result of executing SE restructuring and exceeding the annualized savings target of $35 million. As we have stated in prior earnings call, we have an ongoing funnel of productivity and efficiency initiatives within NSE, designed to reduce expenses beyond this realized SE restructuring-related savings. In our fiscal Q1, NSE’s book to bill ratio was below 1. Now, turning to OSP. Revenue of $54.4 million, down 2.5% year-on-year, reached the high end of our guidance of $51 million to $55 million, driven by a better-than-expected demand in our anti-counterfeiting products. There was no meaningful previous 3D Sensing revenue in our fiscal Q1. Gross margin at 57.7% increased 110 basis points related to favorable product mix. Operating margin of 40.8% declined by 110 basis points from last year due to incremental start-up cost related to 3D Sensing products that continues to ramp in fiscal Q2. Now turning to the balance sheet. Our total cash and short-term investments ending balance was approximately $1.23 billion with total net cash of $307.6 million. Operating cash flow for the quarter was $11 million. In Q1, we repurchased 9.2 million of Viavi stock at a cost basis of $10 per share including commissions. Of the 150 million authorized share buyback, we have repurchased shares worth approximately 105.7 million as of the end of fiscal Q1. With regards to our original $650 million 2033 convertible notes that is portable and callable in August 2018, we have repurchased a total of $186.5 million in notional amounts by the end of fiscal Q1. Our remaining 2033 convertible notes balance is $463.5 million. Our total outstanding debt of $923.5 million includes the recent $460 million 2024 note. We’ll continue to be opportunistic in repurchasing our Viavi stock and retiring our 2033 convertible note. Now, to our guidance. We expect fiscal second quarter 2018 revenue for Viavi to be in the range of $175 million to $195 million, operating margin at 10.3% plus or minus 1%, and EPS to be $0.06 to $0.08. We expect NSE revenue to be at $140 million plus or minus $8 million with operating margin at 4%, plus or minus 1%. For OSP at the macro level, fiscal Q2 is expected to be the tough quarter for anti-counterfeiting products. As we stated last quarter, we expect lower demand in first half fiscal 2018 followed by an expected demand recovery in the second half. We are maintaining our 3D Sensing revenue guidance for fiscal year 2018 between $35 million to $45 million, with significant portion of the revenue recognized in the second half of fiscal 2018. In early October Sonoma County in North California including Santa Rosa experienced devastating wildfires. Fortunately, our OSP facility at Santa Rosa while near an evacuation zone was undamaged but experienced production stoppage. This potential impact on the Sonoma County wildfires coupled with the expected lower volumes in our anti-counterfeiting business and 3D Sensing revenue ramp will pressure OSP’s operating margin in fiscal Q2. Hence, we expect OSP’s revenue for fiscal Q2 to be at $45 million plus or minus $2 million and operating margin at 30% plus or minus 1%. We expect OSP’s revenue and operating margin to recover in fiscal Q3. Our tax expense for fiscal second quarter is expected to be approximately $3.5 million. We expect other income and expenses to reflect a net expense of approximately $0.5 million and our share count to be approximately 233 million shares. In closing, using the midpoint of our fiscal Q2 EPS guidance along with the solid fiscal Q1 EPS performance of $0.11, Viavi’s fiscal first half 2018 EPS is expected to be at a midpoint of $0.18. With an expected OSP revenue and margin recovery in fiscal Q3 and Q4, we expect fiscal second half 2018 EPS to be higher than the expected EPS in our fiscal first half 2018. With that I will turn the call over to Oleg.